Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Bloomberg Customers

Serbia Offers Investors More Time to Bid for Galenika Drug Maker

Serbia gave potential investors two more weeks to make offers for Galenika AD, an unprofitable drugmaker, as the government seeks to turn around money-losing state enterprises.

International pharmaceutical companies will have until April 1, instead of an original March 18 deadline, to submit letters of intent, according to the announcement the Belgrade-based Finance Ministry posted on its website.

Serbia invited companies active in the pharmaceuticals industry over the past five years and with operating revenue of more than 200 million euros ($267 million) in 2011, on Jan. 15 to submit their own proposals for a “privatization model” for Galenika.

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.